T cell–intrinsic prostaglandin E2-EP2/EP4 signaling is critical in pathogenic TH17 cell– driven inflammation  Jinju Lee, MSc, Tomohiro Aoki, MD, PhD, Dean.

Slides:



Advertisements
Similar presentations
Anti–IL-23A mAb BI for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose,
Advertisements

Volume 21, Issue 3, Pages (October 2017)
Volume 39, Issue 5, Pages (November 2013)
Topical application of a vitamin D3 analogue and corticosteroid to psoriasis plaques decreases skin infiltration of TH17 cells and their ex vivo expansion 
MicroRNA-146a suppresses IL-17–mediated skin inflammation and is genetically associated with psoriasis  Ankit Srivastava, MTech, Pernilla Nikamo, PhD,
RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications  Mayte.
Low E-prostanoid 2 receptor levels and deficient induction of the IL-1β/IL-1 type I receptor/COX-2 pathway: Vicious circle in patients with aspirin-exacerbated.
Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic.
IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis  Hyun-Woo Shin, MD, PhD, Dong-Kyu Kim, MD, Min-Hyun Park, MD,
Volume 142, Issue 4, Pages (April 2012)
IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis  Norbert Meyer, MD, Maya Zimmermann, PhD,
FcεRI-mediated amphiregulin production by human mast cells increases mucin gene expression in epithelial cells  Shigeru Okumura, DDS, PhD, Hironori Sagara,
Pentraxin 3 deletion aggravates allergic inflammation through a TH17-dominant phenotype and enhanced CD4 T-cell survival  Jyoti Balhara, MSc, Lianyu Shan,
Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis  Jennifer D. Hamilton, PhD, Mayte Suárez-Fariñas,
Topical application of a vitamin D3 analogue and corticosteroid to psoriasis plaques decreases skin infiltration of TH17 cells and their ex vivo expansion 
IL-31 regulates differentiation and filaggrin expression in human organotypic skin models  Christian Cornelissen, MSc, Yvonne Marquardt, Katharina Czaja,
IL-33 induces innate lymphoid cell–mediated airway inflammation by activating mammalian target of rapamycin  Robert J. Salmond, PhD, Ananda S. Mirchandani,
Anti–IL-23A mAb BI for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose,
Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic.
D prostanoid receptor 2 (chemoattractant receptor–homologous molecule expressed on TH2 cells) protein expression in asthmatic patients and its effects.
IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis  James G. Krueger, MD, Scott Fretzin, MD, Mayte Suárez-Fariñas,
Signaling through FcRγ-associated receptors on dendritic cells drives IL-33–dependent TH2-type responses  Melissa Y. Tjota, BA, Cara L. Hrusch, PhD, Kelly.
Targeting CD8+ T cells prevents psoriasis development
Cysteinyl leukotriene E4 activates human group 2 innate lymphoid cells and enhances the effect of prostaglandin D2 and epithelial cytokines  Maryam Salimi,
Effects of lidocaine on regulatory T cells in atopic dermatitis
Volume 39, Issue 5, Pages (November 2013)
Prostaglandin E2 stimulates adaptive IL-22 production and promotes allergic contact dermatitis  Calum T. Robb, PhD, Henry J. McSorley, PhD, Jinju Lee,
Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytes 
Jovana Maric, MSc, Avinash Ravindran, MSc, Luca Mazzurana, MSc, Åsa K
Culture medium from TNF-α–stimulated mesenchymal stem cells attenuates allergic conjunctivitis through multiple antiallergic mechanisms  Wenru Su, MD,
Kathleen R. Bartemes, BA, Gail M. Kephart, BS, Stephanie J
Transcriptional profiling identifies the long noncoding RNA plasmacytoma variant translocation (PVT1) as a novel regulator of the asthmatic phenotype.
Guselkumab (an IL-23–specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis  Howard Sofen, MD, Stacy.
Jia Guo, MD, Xin Lin, PhD, Marc A
Human mast cells drive memory CD4+ T cells toward an inflammatory IL-22+ phenotype  Nicolas Gaudenzio, PhD, Camille Laurent, MD, Salvatore Valitutti,
Prostaglandin E2 suppresses allergic sensitization and lung inflammation by targeting the E prostanoid 2 receptor on T cells  Zbigniew Zasłona, PhD, Katsuhide.
IL-2–inducible T-cell kinase modulates TH2-mediated allergic airway inflammation by suppressing IFN-γ in naive CD4+ T cells  Arun K. Kannan, MS, Nisebita.
Anti–IL-23A mAb BI for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose,
Wei Xu, Shengxian Jia, Ping Xie, Aimei Zhong, Robert D
The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling  Wataru.
Fibronectin is a TH1-specific molecule in human subjects
Dichotomy of short and long thymic stromal lymphopoietin isoforms in inflammatory disorders of the bowel and skin  Giulia Fornasa, PhD, Katerina Tsilingiri,
Humanized anti–IFN-γ (HuZAF) in the treatment of psoriasis
Imatinib stimulates prostaglandin E2 and attenuates cytokine release via EP4 receptor activation  Thomas Bärnthaler, MD, Katharina Jandl, PhD, Heinz Sill,
Volume 40, Issue 6, Pages (June 2014)
Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis  Deepti R. Nagarkar, PhD, Julie A. Poposki,
Prostaglandin E2 suppresses allergic sensitization and lung inflammation by targeting the E prostanoid 2 receptor on T cells  Zbigniew Zasłona, PhD, Katsuhide.
T-bet inhibits innate lymphoid cell–mediated eosinophilic airway inflammation by suppressing IL-9 production  Ayako Matsuki, MD, Hiroaki Takatori, MD,
Fibronectin is a TH1-specific molecule in human subjects
Orally administered TGF-β is biologically active in the intestinal mucosa and enhances oral tolerance  Takashi Ando, MD, PhD, Kyosuke Hatsushika, MD,
Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
T-bet inhibits innate lymphoid cell–mediated eosinophilic airway inflammation by suppressing IL-9 production  Ayako Matsuki, MD, Hiroaki Takatori, MD,
Programmed cell death ligand 2 regulates TH9 differentiation and induction of chronic airway hyperreactivity  Jerome Kerzerho, PhD, Hadi Maazi, PhD, Anneliese.
Volume 22, Issue 5, Pages e5 (November 2017)
Volume 21, Issue 3, Pages (October 2017)
Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis  Jennifer D. Hamilton, PhD, Mayte Suárez-Fariñas,
Prostaglandin D2 and leukotriene E4 synergize to stimulate diverse TH2 functions and TH2 cell/neutrophil crosstalk  Luzheng Xue, PhD, Joannah Fergusson,
Volume 22, Issue 5, Pages e5 (November 2017)
Josée Lamoureux, PhD, Jana Stankova, PhD, Marek Rola-Pleszczynski, MD 
IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis  Hyun-Woo Shin, MD, PhD, Dong-Kyu Kim, MD, Min-Hyun Park, MD,
Leukotriene D4 and prostaglandin E2 signals synergize and potentiate vascular inflammation in a mast cell–dependent manner through cysteinyl leukotriene.
The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling  Wataru.
MicroRNA-146a suppresses IL-17–mediated skin inflammation and is genetically associated with psoriasis  Ankit Srivastava, MTech, Pernilla Nikamo, PhD,
Thromboxane A2 facilitates IL-17A production from Vγ4+ γδ T cells and promotes psoriatic dermatitis in mice  Yuri Ueharaguchi, MD, Tetsuya Honda, MD,
Prostaglandin E receptor subtype EP3 in conjunctival epithelium regulates late-phase reaction of experimental allergic conjunctivitis  Mayumi Ueta, MD,
Correlation between CCL26 production by human bronchial epithelial cells and airway eosinophils: Involvement in patients with severe eosinophilic asthma 
Prostaglandin E2–EP3 signaling suppresses skin inflammation in murine contact hypersensitivity  Tetsuya Honda, MD, PhD, Toshiyuki Matsuoka, MD, PhD, Mayumi.
Neuropeptide signaling through neurokinin-1 and neurokinin-2 receptors augments antigen presentation by human dendritic cells  Junya Ohtake, PhD, Shun.
Possible new therapeutic strategy to regulate atopic dermatitis through upregulating filaggrin expression  Atsushi Otsuka, MD, PhD, Hiromi Doi, MS, Gyohei.
CCL17/thymus and activation-regulated chemokine induces calcitonin gene–related peptide in human airway epithelial cells through CCR4  Kandace Bonner,
Presentation transcript:

T cell–intrinsic prostaglandin E2-EP2/EP4 signaling is critical in pathogenic TH17 cell– driven inflammation  Jinju Lee, MSc, Tomohiro Aoki, MD, PhD, Dean Thumkeo, MD, PhD, Ratklao Siriwach, PhD, Chengcan Yao, PhD, Shuh Narumiya, MD, PhD  Journal of Allergy and Clinical Immunology  Volume 143, Issue 2, Pages 631-643 (February 2019) DOI: 10.1016/j.jaci.2018.05.036 Copyright © 2018 The Authors Terms and Conditions

Journal of Allergy and Clinical Immunology 2019 143, 631-643DOI: (10 Journal of Allergy and Clinical Immunology 2019 143, 631-643DOI: (10.1016/j.jaci.2018.05.036) Copyright © 2018 The Authors Terms and Conditions

Fig 1 IL-23 mobilizes the endogenous PGE2-EP2/EP4-cAMP-PKA pathway to facilitate TH17 expansion through synergistic Il23r induction. A and B, Expansion of the TH17 population by PGE2 and IL-23. CD4+ T cells were differentiated with TGF-β1 and IL-6 to TH17 cells for 4 days and then stimulated with 100 nmol/L PGE2 in the absence or presence of IL-23 (10 ng/mL) for an additional 3 days. The cells were examined by using fluorescence-activated cell sorting for IL-17A and IFN-γ (Fig 1, A) and by using quantitative RT-PCR for Il17a expression (Fig 1, B). C-E, Effects of PGE2, 100 μM of an agonist selective to each EP subtype, and related compounds on Il23r expression. TH17 cells were incubated with 100 nmol/L PGE2, an agonist selective to each EP subtype, ONO-DI-004 (EP1), ONO-AE1-259 (EP2), ONO-AE-248 (EP3), or ONO-AE1-329 (EP4), 100 μmol/L db-cAMP, 10 μmol/L forskolin (FSK), or 100 μmol/L 3-isobutyl-1-methylxanthine (IBMX) with or without IL-23. Il23r expression (Fig 1, C and D) or IL-17A concentrations in culture supernatants (Fig 1, E) were examined. F and G, Expression of Il23r in TH17 cells stimulated with 100 μmol/L db-cAMP, 300 μmol/L N6-Bnz-cAMP (a PKA agonist), 300 μmol/L 8-pCTP-2′-O-Me-cAMP (an Epac activator; Fig 1, F), or 10 μM H-89 (a PKA inhibitor; Fig 1, G) with or without IL-23. All bars indicate means ± SEMs (n = 3). *P < .05, **P < .01, and ***P < .001. Journal of Allergy and Clinical Immunology 2019 143, 631-643DOI: (10.1016/j.jaci.2018.05.036) Copyright © 2018 The Authors Terms and Conditions

Fig 2 IL-23 self-amplifies its own signaling through a T cell–intrinsic positive feedback COX2–PGE2–cAMP–IL-23R loop. A, Expression of COX2 mRNA (Ptgs2) in TH17 cells or TH17 cells cultured further in the presence or absence of IL-23 for 3 days, as determined by using quantitative RT-PCR. B, Concentrations of PGE2 in culture supernatants of TH17 cells in the presence or absence of IL-23 and indomethacin determined by means of ELISA. n.d., Not detected. C, Il23r expression in TH17 cells stimulated with PGE2 and IL-23 in the presence or absence of 100 μM indomethacin for 3 days. D, Il23r expression in TH17 cells stimulated with PGE2 and IL-23 in the presence or absence of EP2 (PF-04418948, 300 μM) and/or EP4 (ONO-AE3-208, 100 μM) antagonists for 3 days. All bars indicate means ± SEMs (n = 3). *P < .05, **P < .01, and ***P < .001. Journal of Allergy and Clinical Immunology 2019 143, 631-643DOI: (10.1016/j.jaci.2018.05.036) Copyright © 2018 The Authors Terms and Conditions

Fig 3 STAT3, CREB1, and NF-κB mediate cAMP- and IL-23–induced Il23r expression in TH17 cells. A, Effect of STAT3 inhibitor VII on Il23r expression in TH17 cells stimulated with db-cAMP, IL-23, or both for 3 days. B, Western blot analysis of phospho-Y705 STAT3 and α-tubulin as a loading control in TH17 cells cultured as described in the Methods section in this article's Online Repository. Representative images from 2 independent experiments are shown. C, Effect of KG-501 on Il23r expression in TH17 cells stimulated by using db-cAMP, IL-23, or both. D, Effects of RNA interference for CREB1 on Il23r expression (left) and Creb1 expression to confirm CREB knockdown efficiency (right). RNA interference, subsequent culture, and stimulation of TH17 cells were performed, as described in the Methods section in this article's Online Repository. E, Western blot analysis of phospho-S536 NF-κB p65 (pp65), phospho-S933 NF-κB p105 (pp105), p65, p105/p50, and α-tubulin in TH17 cells stimulated as described in the Methods section in this article's Online Repository. Representative images from 2 independent experiments are shown. F and G, Effects of p105 KO (Fig 3, F) or 50 μM CTP-NBD (Fig 3, G) on Il23r expression in TH17 cells stimulated with db-cAMP, IL-23, or both for 3 days. All bars indicate means ± SEMs (n = 3 for Fig 3, A, C, F, and G; n = 18 in Fig 3, B). ***P < .001. Journal of Allergy and Clinical Immunology 2019 143, 631-643DOI: (10.1016/j.jaci.2018.05.036) Copyright © 2018 The Authors Terms and Conditions

Fig 4 Activation of the COX2-PGE2-EP2/EP4-cAMP pathway confers a pathogenic TH17 phenotype. A, Microarray analysis of gene expression profiles in TH17 cells stimulated with db-cAMP, IL-23, or both. Venn diagram analysis of 2-fold upregulated or downregulated genes compared with the vehicle control (Veh) on each stimulus (P < .05, 1-way ANOVA; n = 3; left and right, respectively). B, Heat map analysis of expression of selected genes from each cluster. C, Quantitative RT-PCR analysis of expression of representative genes of TH17 signature and immune activation in response to db-cAMP, IL-23, or db-cAMP and IL-23 in combination. D, Quantitative RT-PCR analysis of expression of a representative inflammation suppressor gene, Il10, in response to db-cAMP, IL-23, or db-cAMP and IL-23 in combination. All bars in Fig 4, C and D, indicate means ± SEMs (n = 3). *P < .05, **P < .01, and ***P < .001. Journal of Allergy and Clinical Immunology 2019 143, 631-643DOI: (10.1016/j.jaci.2018.05.036) Copyright © 2018 The Authors Terms and Conditions

Fig 5 PGE2-EP2/EP4 signaling in T cells is required for IL-23–driven psoriatic skin inflammation. A-D, Ear swelling (n = 16-17; Fig 5, A), representative hematoxylin and eosin staining of the histologic section of the ear (n = 3-4; Fig 5, B), number of IL-17A+ and IL-17A+IFN-γ+CD4+ T cells of the ear (Fig 5, C), and gene expression of Il17a, Ifng, and Il23r in whole ear tissue (Fig 5, D) of WT or EP2 KO mice subcutaneously injected with IL-23 or PBS into the ear daily. An EP4 antagonist (AS1954813, 100 mg/kg) or vehicle was orally administered twice a day to the indicated mice. Bars in Fig 5, B = 50 μm. Representative quantification results of the cell number in each population from 4 independent fluorescence-activated cell sorting experiments are shown in Fig 5, C (n = 3). Gene expression was indicated as fold change compared with PBS-injected ears in Fig 5, D (n = 3). E and F, EP2flox/floxEP4flox/floxLck-Cre+ mice and control WT Lck-Cre+ mice were subjected to an IL-23–induced psoriasis model, and ear swelling (n = 11 and 7, respectively; Fig 5, E) and numbers of IL-17A+ and IL-17A+IFN-γ+CD4+ T cells in the ear (n = 7 and 3, respectively; Fig 5, F) were analyzed. All bars indicate means ± SEMs. *P < .05, **P < .01, and ***P < .001. Journal of Allergy and Clinical Immunology 2019 143, 631-643DOI: (10.1016/j.jaci.2018.05.036) Copyright © 2018 The Authors Terms and Conditions

Fig 6 PGE2 signaling positively correlates with the IL-23/TH17 pathway in human psoriatic skin biopsy specimens. A, Expression profiles of genes related to PGE2 signaling and TH17 signature genes in human nonlesional (NL) or lesional (PL) skin biopsy specimens from patients with psoriasis (n = 58) and skin samples from healthy control subjects (HC; n = 64). The z score transformed values of the microarray gene expression data set GSE13355 were used. The TH17 score was generated based on the average expression level of IL23A, IL12B, IL23R, IL17A, IL17F, and IL22 genes. B, Correlations of PTGES, PTGES2, HPGD, and PTGER4 gene expression versus those of the TH17 score. Black, green, and red dots indicate healthy control, nonlesional, and lesional psoriatic biopsy specimens, respectively. C, Expression profiles of genes related to PGE2 synthases and TH17 signature genes in human lesional skin biopsy specimens from patients with moderate-to-severe psoriasis before (Baseline, n = 22) or 12 weeks after treatment with the IL-23–specific mAb guselkumab (n = 8). The z score transformed values of the microarray gene expression data set GSE51440 were used. D, Correlations of gene expression of PTGS2 and PTGES versus that of IL23R. P values were calculated by using nonparametric Wilcoxon-Mann-Whitney tests (Fig 6, A and C) or the nonparametric Spearman correlation test (Fig 6, B and D). Journal of Allergy and Clinical Immunology 2019 143, 631-643DOI: (10.1016/j.jaci.2018.05.036) Copyright © 2018 The Authors Terms and Conditions